Lyso‐phosphatidylcholine: A potential metabolomic biomarker for alcoholic liver disease?
Horia Stefanescu, Alina Suciu, Florina Romanciuc, Dana Crisan, Bogdan Procopet, Corina Radu, Marcel Tantau, Carmen Socaciu, Mircea Grigorescu – 28 April 2016
Abnormal liver tests after liver transplantation
Andrew Fedoravicius, Michael Charlton – 27 April 2016
Liver injury due to herbal and dietary supplements: A review of individual ingredients
Elizabeth Zheng, Victor Navarro – 27 April 2016
Granulomas of the liver
Emma L. Culver, Jennifer Watkins, Rachel H. Westbrook – 27 April 2016
Distinguishing immunoglobulin G4–related disease from its pancreatobiliary mimics: Are we there now?
James H. Tabibian, Keith D. Lindor – 27 April 2016
Finding a new role for NEMO: A key player in preventing hepatocyte apoptosis and liver tumorigenesis by inhibiting RIPK1
I‐Fang Hsin, Erica Montano, Ekihiro Seki – 27 April 2016
Polymorphisms in STAT4 are not associated with treatment response and spontaneous clearance of hepatitis C virus in europeans
Anastasia Asimakopoulos, Alessandra Mangia, Gregory J. Dore, Andrew R. Lloyd, Jacob George, Mohammed Eslam – 27 April 2016
The liver in systemic disease: Sepsis and critical illness
William Bernal – 27 April 2016
Transjugular intrahepatic portosystemic shunt for refractory ascites in patients with high model for end‐stage liver disease scores
Kavish R. Patidar, Arun J. Sanyal – 27 April 2016
Cryptogenic cirrhosis: Current knowledge and future directions
Alex Mercado‐Irizarry, Esther A. Torres – 27 April 2016